Addressing the GLP-1 Disruption and Nutritional Wellness
A major challenge for US corporate wellness in 2026 is managing the surge in demand for GLP-1 medications (like Ozempic and Wegovy) for weight management.
With healthcare costs rising by over 10% annually, many employers are pairing these expensive prescriptions with mandatory "Lifestyle Management" programs. These programs provide access to registered dietitians and behavior-change coaching to ensure that the health benefits of the medication are sustainable long-term. Nutritional wellness has also evolved to include "functional nutrition"—providing healthy, protein-packed food options in the office and hosting virtual healthy cooking demos. By focusing on nutrition as a lever for both short-term energy and long-term chronic disease prevention, companies are taking a proactive stance against the rising costs of obesity-related conditions.